Clinical Quality Language (CQL) is an HL7 specification for the expression of clinical knowledge that can be used within both the Clinical Decision Support (CDS) and Clinical Quality Measurement (CQM) ...

Artificial Intelligence (AI) is reshaping the field of data visualization, making it faster, smarter, and more accessible than ever before. “AI is not just about fancier dashboards. Think about ...

today announced the latest release of Cloudera Data Visualization, extending its AI capabilities to customers operating in on-premises environments. This new offering is a high-performance AI tool ...

Data visualization is the visual depiction of data through the use of graphs, plots, and informational graphics. Its practitioners use statistics and data science to convey the meaning behind data in ...

Available across multi-cloud and hybrid environments, Cloudera Data Visualization includes integrated AI visualization and natural language querying for enterprises to improve collaboration and ...

Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, today announced new data to be presented at the 2025 American Society of ...

Clinical trial data sharing among researchers, patients and sponsor companies has massive potential for catalysing scientific innovation. Ulo Palm considers the latest initiatives and their impact ...

Simplify with purpose: prioritize what adds value: Modern trials are overloaded with data and systems that often yield diminishing returns. To reduce burden on sites and patients, clinical teams must ...

Trish Groves provides an overview of the increasing demand to make clinical trial data transparent. Now such calls to make clinical trial data transparent – along with openly accessible ...

Rutgers researchers will apply Neuro-Symbolic AI techniques to address challenges in clinical data interpretation, academic operations, and societal outcomes ...

ECRI, a global nonprofit advancing evidence-based healthcare, has expanded offerings in its clinical evidence assessments ...